Results 31 to 40 of about 2,415 (182)

Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients [PDF]

open access: yesFarmacia Hospitalaria, 2019
Objective: To calculate the persistence, over a period of eight years, the retention rate of first and second-line of treatment with biological agents in patients with rheumatoid arthritis, spondyloarthritis and psoriatic arthritis and to compare ...
María Ángeles González-Fernández   +5 more
doaj   +1 more source

The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy [PDF]

open access: yesArthritis & Rheumatism, 1991
AbstractClassification criteria for most of the disorders belonging to the spondylarthropathy group already exist. However, the spectrum of spondylarthropathy is wider than the sum of these disorders suggests. Sero‐negative oligoarthritis, dactylitis or polyarthritis of the lower extremities, heel pain due to enthesitis, and other undifferentiated ...
Maxime Dougados   +11 more
openaire   +2 more sources

Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six‐Month Results of a Placebo‐Controlled Trial

open access: yesArthritis &Rheumatology, Volume 73, Issue 5, Page 806-815, May 2021., 2021
Objective To investigate the efficacy of 16‐week treatment with etanercept (ETN) in patients with suspected nonradiographic axial spondyloarthritis (SpA). Methods Tumor necrosis factor inhibitor–naive patients with inflammatory back pain with at least 2 SpA features and high disease activity (Bath Ankylosing Spondylitis Disease Activity Index score ≥4),
Tamara Rusman   +9 more
wiley   +1 more source

Update in spondylarthropathy [PDF]

open access: yesArthritis Care & Research, 2004
Ankylosing spondylitis (AS) is the most common type of spondylarthropathy seen in clinical practice. Several reports have appeared in the past 2 years that have significantly advanced our understanding of the pathogenesis and treatment of this disease.
openaire   +2 more sources

Collagenous Colitis and Spondylarthropathy [PDF]

open access: yesCase Reports in Medicine, 2012
Collagenous colitis is a recent cause of chronic diarrhea. Cooccurrence with spondylarthropathy is rare. We describe two cases: one man and one woman of 33 and 20 years old were suffering from spondylarthropathy. They then developed collagenous colitis, 4 and 14 years after the onset of spondylarthropathy.
Kaouther Ben Abdelghani   +7 more
openaire   +3 more sources

FRI0672 Anti-saccharomyces cerevisiae antibodies in spondylarthropathies: prevalence and associations with disease phenotype

open access: yesFRIDAY, 15 JUNE 2018, 2018
Background: It has been speculated that increased gut inflamation is of aetiopathogenic importance in the development of Spondylarthropathies (Spa). Serological markers, as anti-Saccharomyces cerevisiae antibodies (ASCA), which are rarely positive in ...
R. Ferreira   +8 more
semanticscholar   +1 more source

Bamboo spine – X-ray findings of ankylosing spondylitis revisited

open access: yesSouth African Journal of Radiology, 2012
Ankylosing spondylitis is a debilitating disease that is one of the seronegative spondylarthropathies, affecting more males than females in the proportion of about 6:1 in the age group 15 - 35 years of age.
Antoinette Reinders, Matthys J van Wyk
doaj   +1 more source

Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review

open access: yesRheumatology and Therapy, 2019
Introduction Secukinumab is a fully human anti-interleukin 17A monoclonal antibody approved for the treatment of psoriatic arthritis (PsA) in the United States.
Prashanth Sunkureddi   +5 more
doaj   +1 more source

Biological therapy in treatment of uveitis. Contemporary trends

open access: yesJournal of Ophthalmology, 2017
Uveitis is a cause of blindness in about 10% of cases. According to many studies, TNF-? plays an important role in the development of uveitis. Anti-TNF-? are widely used in rheumatology and recently in ophthalmology.
A.V. Zborovskaia, A.E. Dorokhova
doaj   +1 more source

Musculoskeletal Manifestations in Inflammatory Bowel Disease

open access: yesCanadian Journal of Gastroenterology, 2001
Muscoloskeletal manifestations are the most common extraintestinal complications of inflammatory bowel disease. Wide ranges in prevalence have been reported, depending on the criteria used to define spondylarthropathy.
Giovanni Fornaciari   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy